Fusionex, IMU catalyse medical education, research via big data analytics
KUALA LUMPUR, Sept 20 -- Fusionex and the International Medical University (IMU) have taken a bold step to integrate big data analytics (BDA) and artificial intelligence (AI) in IMU’s medical and health sciences programmes.
Fusionex and IMU expressed their commitment with the exchange of a Memorandum of Agreement (MoA), by IMU Deputy Vice-Chancellor, Professor Peter Pook and Fusionex Founder and Group Chief Executive Officer, Datuk Seri Ivan Teh.
The MoA sees both parties leveraging on their respective strengths – Fusionex utilising BDA and AI, and IMU lending its expertise and knowledge in the healthcare industry – to work together on various aspects of medical research & development, including cancer informatics, advanced drugs, vaccine design and healthcare analytics.
In order to equip future healthcare providers with the right set of skills and knowledge, this collaboration will see five IMU undergraduate programmes, each piloting a BDA module.
The programmes are Bachelor of Pharmacy (Hons); BSc (Hons) in Medical Biotechnology; BSc (Hons) in Dietetics with Nutrition; BSc (Hons) in Nutrition; and, BSc (Hons) in Biomedical Science.
These will be some of the first non-ICT degree programmes to integrate BDA as part of its syllabus.
These programmes will provide four outcomes - an overview of the analytics life cycle, how analytics is contributing to the healthcare industry, why making data-driven decisions is key for an organisation, and effectively using analytical and AI skills in solving healthcare-related problems.
-- BERNAMA
Fusionex and IMU expressed their commitment with the exchange of a Memorandum of Agreement (MoA), by IMU Deputy Vice-Chancellor, Professor Peter Pook and Fusionex Founder and Group Chief Executive Officer, Datuk Seri Ivan Teh.
The MoA sees both parties leveraging on their respective strengths – Fusionex utilising BDA and AI, and IMU lending its expertise and knowledge in the healthcare industry – to work together on various aspects of medical research & development, including cancer informatics, advanced drugs, vaccine design and healthcare analytics.
In order to equip future healthcare providers with the right set of skills and knowledge, this collaboration will see five IMU undergraduate programmes, each piloting a BDA module.
The programmes are Bachelor of Pharmacy (Hons); BSc (Hons) in Medical Biotechnology; BSc (Hons) in Dietetics with Nutrition; BSc (Hons) in Nutrition; and, BSc (Hons) in Biomedical Science.
These will be some of the first non-ICT degree programmes to integrate BDA as part of its syllabus.
These programmes will provide four outcomes - an overview of the analytics life cycle, how analytics is contributing to the healthcare industry, why making data-driven decisions is key for an organisation, and effectively using analytical and AI skills in solving healthcare-related problems.
-- BERNAMA
Comments
Post a Comment